Is end-of-life anticipatory prescribing always enough?
- PMID: 37192773
- DOI: 10.1136/bmj.p1106
Is end-of-life anticipatory prescribing always enough?
Conflict of interest statement
We have read and understood BMJ policy on declaration of interests and have no competing interests. BB, PH, BM, KP, and SB are researching end of life injectable medication practice. BB is supported by the Wellcome Trust [225577/Z/22/Z]. SB is supported by the National Institute for Health and Care Research Applied Research Collaboration East of England at Cambridgeshire and Peterborough NHS Foundation Trust.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources